Inovio Pharmaceuticals
INO
#9070
Rank
โ‚ฌ99.74 M
Marketcap
1,45ย โ‚ฌ
Share price
-1.19%
Change (1 day)
-25.19%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -2,53ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,51ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,44ย โ‚ฌ an increase over its 2023 EPS that were of -5,30ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,53ย โ‚ฌ-26.47%
2024-3,44ย โ‚ฌ-35.14%
2023-5,30ย โ‚ฌ-56.62%
2022-12,23ย โ‚ฌ-19.54%
2021-15,20ย โ‚ฌ35.9%
2020-11,18ย โ‚ฌ-11.57%
2019-12,65ย โ‚ฌ15.24%
2018-10,97ย โ‚ฌ-2.78%
2017-11,29ย โ‚ฌ6.93%
2016-10,56ย โ‚ฌ134.88%
2015-4,49ย โ‚ฌ-29.51%
2014-6,37ย โ‚ฌ-57.34%
2013-14,94ย โ‚ฌ146.55%
2012-6,06ย โ‚ฌ20.83%
2011-5,02ย โ‚ฌ-29.41%
2010-7,11ย โ‚ฌ-48.48%
2009-13,80ย โ‚ฌ10%
2008-12,54ย โ‚ฌ11.11%
2007-11,29ย โ‚ฌ-41.3%
2006-19,23ย โ‚ฌ-66.91%
2005-58,11ย โ‚ฌ110.61%
2004-27,59ย โ‚ฌ-61.63%
2003-71,90ย โ‚ฌ186.67%
2002-25,08ย โ‚ฌ
2001N/A-100%
2000-20,07ย โ‚ฌ-62.42%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,70ย โ‚ฌ-486.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,41ย โ‚ฌ-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,18ย โ‚ฌ-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5,68ย โ‚ฌ-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,36ย โ‚ฌ-353.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,28ย โ‚ฌ-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-1,09ย โ‚ฌ-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA